Skip to main content
Erschienen in: Pediatric Nephrology 10/2008

01.10.2008 | Original Article

Deficiency of intrarenal angiotensin II type 2 receptor impairs paired homeo box-2 and N-myc expression during nephrogenesis

verfasst von: Yun-Wen Chen, Stella Tran, Isabelle Chenier, John S. D. Chan, Julie R. Ingelfinger, Tadashi Inagami, Shao-Ling Zhang

Erschienen in: Pediatric Nephrology | Ausgabe 10/2008

Einloggen, um Zugang zu erhalten

Abstract

We previously demonstrated that angiotensin II (Ang II) stimulates paired homeo box-2 (Pax-2) via the Ang II type 2 receptor (AT2R). The Pax-2 gene and N-myc play pivotal roles in renal morphogenesis via their effects on cell proliferation and differentiation in embryonic mesenchymal cells and embryonic mouse kidneys. Since AT2R knock-out (KO) mice have a phenotype that is similar to that of humans with congenital renal and urinary tract anomalies (CAKUT) and develop hypertension in adulthood, these mice and wild-type controls were used for this study. Embryonic kidneys isolated from E12 to term gestation were cultured in Dulbecco’s modified Eagle’s medium (DMEM) with or without Ang II (10−6 M) for 24 h ex vivo. Renal morphogenesis was histologically assessed. Mean glomerular tuft volume was determined by the method of Weibel and Gomez with the aid of image analysis software. Pax-2 and N-myc gene expression were determined by immunostaining as well as by Western blotting and real-time-quantitative polymerase chain reaction (RT-qPCR). Glomerular size was significantly smaller, and Pax-2 and N-myc expression down-regulated, in kidneys of AT2R KO mice compared with those of wild-type mice. In ex vivo studies, Ang II stimulated Pax-2 and N-myc mRNA expression in embryonic kidneys of wild-type mice, but this stimulatory effect was absent in embryonic kidneys of AT2R KO mice. Taken together, these data indicate that intrarenal AT2R plays an important role in nephrogenesis. Deficiency of AT2R may impair both Pax-2 and N-myc expression, eventually resulting in glomerular hyperfiltration that may, ultimately, lead to later development of hypertension.
Literatur
1.
Zurück zum Zitat Guron G, Friberg P (2000) An intact renin-angiotensin system is a prerequisite for normal renal development. J Hypertens 18:123–137PubMed Guron G, Friberg P (2000) An intact renin-angiotensin system is a prerequisite for normal renal development. J Hypertens 18:123–137PubMed
2.
Zurück zum Zitat Iosipiv IV, Schroeder M (2003) A role for angiotensin II AT1 receptors in ureteric bud cell branching. Am J Physiol Renal Physiol 285:F199–F207PubMed Iosipiv IV, Schroeder M (2003) A role for angiotensin II AT1 receptors in ureteric bud cell branching. Am J Physiol Renal Physiol 285:F199–F207PubMed
3.
Zurück zum Zitat Butkus A, Albiston A, Alcorn D, Giles M, McCausland J, Moritz K, Zhuo J, Wintour EM (1997) Ontogeny of angiotensin II receptors, types 1 and 2, in ovine mesonephros and metanephros. Kidney Int 52:628–636PubMed Butkus A, Albiston A, Alcorn D, Giles M, McCausland J, Moritz K, Zhuo J, Wintour EM (1997) Ontogeny of angiotensin II receptors, types 1 and 2, in ovine mesonephros and metanephros. Kidney Int 52:628–636PubMed
4.
Zurück zum Zitat Carey RM, Wang ZQ, Siragy HM (1999) Novel actions of angiotensin II via its renal type-2 AT(2) receptor. Curr Hypertens Rep 1:151–157PubMed Carey RM, Wang ZQ, Siragy HM (1999) Novel actions of angiotensin II via its renal type-2 AT(2) receptor. Curr Hypertens Rep 1:151–157PubMed
5.
Zurück zum Zitat Chen Y, Lasaitiene D, Friberg P (2004) The renin-angiotensin system in kidney development. Acta Physiol Scand 181:529–535PubMed Chen Y, Lasaitiene D, Friberg P (2004) The renin-angiotensin system in kidney development. Acta Physiol Scand 181:529–535PubMed
6.
Zurück zum Zitat Lasaitiene D, Chen Y, Adams MA, Friberg P (2006) Further insights into the role of angiotensin II in kidney development. Clin Physiol Funct Imaging 26:197–204PubMed Lasaitiene D, Chen Y, Adams MA, Friberg P (2006) Further insights into the role of angiotensin II in kidney development. Clin Physiol Funct Imaging 26:197–204PubMed
7.
Zurück zum Zitat Norwood VF, Craig MR, Harris JM, Gomez RA (1997) Differential expression of angiotensin II receptors during early renal morphogenesis. Am J Physiol 272:R662–R668PubMed Norwood VF, Craig MR, Harris JM, Gomez RA (1997) Differential expression of angiotensin II receptors during early renal morphogenesis. Am J Physiol 272:R662–R668PubMed
8.
Zurück zum Zitat Timmermans PB, Wong PC, Chiu AT, Herblin WF, Benfield P, Carini DJ, Lee RJ, Wexler RR, Saye JA, Smith RD (1993) Angiotensin II receptors and angiotensin II receptor antagonists. Pharmacol Rev 45:205–251PubMed Timmermans PB, Wong PC, Chiu AT, Herblin WF, Benfield P, Carini DJ, Lee RJ, Wexler RR, Saye JA, Smith RD (1993) Angiotensin II receptors and angiotensin II receptor antagonists. Pharmacol Rev 45:205–251PubMed
9.
Zurück zum Zitat Gomez RA, Norwood VF (1999) Recent advances in renal development. Curr Opin Pediatr 11:135–140PubMed Gomez RA, Norwood VF (1999) Recent advances in renal development. Curr Opin Pediatr 11:135–140PubMed
10.
Zurück zum Zitat Nishimura H, Yerkes E, Hohenfellner K, Miyazaki Y, Ma J, Hunley TE, Yoshida H, Ichiki T, Threadgill D, Phillips JA III, Hogan BM, Fogo A, Brock JW III, Inagami T, Ichikawa I (1999) Role of the angiotensin type 2 receptor gene in congenital anomalies of the kidney and urinary tract, CAKUT, of mice and men. Mol Cell 3:1–10PubMed Nishimura H, Yerkes E, Hohenfellner K, Miyazaki Y, Ma J, Hunley TE, Yoshida H, Ichiki T, Threadgill D, Phillips JA III, Hogan BM, Fogo A, Brock JW III, Inagami T, Ichikawa I (1999) Role of the angiotensin type 2 receptor gene in congenital anomalies of the kidney and urinary tract, CAKUT, of mice and men. Mol Cell 3:1–10PubMed
11.
Zurück zum Zitat Ichiki T, Labosky PA, Shiota C, Okuyama S, Imagawa Y, Fogo A, Niimura F, Ichikawa I, Hogan BL, Inagami T (1995) Effects on blood pressure and exploratory behaviour of mice lacking angiotensin II type-2 receptor. Nature 377:748–750PubMed Ichiki T, Labosky PA, Shiota C, Okuyama S, Imagawa Y, Fogo A, Niimura F, Ichikawa I, Hogan BL, Inagami T (1995) Effects on blood pressure and exploratory behaviour of mice lacking angiotensin II type-2 receptor. Nature 377:748–750PubMed
12.
Zurück zum Zitat Dziarmaga A, Eccles M, Goodyer P (2006) Suppression of ureteric bud apoptosis rescues nephron endowment and adult renal function in Pax2 mutant mice. J Am Soc Nephrol 17:1568–1575PubMed Dziarmaga A, Eccles M, Goodyer P (2006) Suppression of ureteric bud apoptosis rescues nephron endowment and adult renal function in Pax2 mutant mice. J Am Soc Nephrol 17:1568–1575PubMed
13.
Zurück zum Zitat Hueber PA, Waters P, Clarke P, Eccles M, Goodyer P (2006) PAX2 inactivation enhances cisplatin-induced apoptosis in renal carcinoma cells. Kidney Int 69:1139–1145PubMed Hueber PA, Waters P, Clarke P, Eccles M, Goodyer P (2006) PAX2 inactivation enhances cisplatin-induced apoptosis in renal carcinoma cells. Kidney Int 69:1139–1145PubMed
14.
Zurück zum Zitat Zhang SL, Guo J, Moini B, Ingelfinger JR (2004) Angiotensin II stimulates Pax-2 in rat kidney proximal tubular cells: impact on proliferation and apoptosis. Kidney Int 66:2181–2192PubMed Zhang SL, Guo J, Moini B, Ingelfinger JR (2004) Angiotensin II stimulates Pax-2 in rat kidney proximal tubular cells: impact on proliferation and apoptosis. Kidney Int 66:2181–2192PubMed
15.
Zurück zum Zitat Zhang SL, Moini B, Ingelfinger JR (2004) Angiotensin II increases Pax-2 expression in fetal kidney cells via the AT2 receptor. J Am Soc Nephrol 15:1452–1465PubMed Zhang SL, Moini B, Ingelfinger JR (2004) Angiotensin II increases Pax-2 expression in fetal kidney cells via the AT2 receptor. J Am Soc Nephrol 15:1452–1465PubMed
16.
Zurück zum Zitat Zhang SL, Chen YW, Tran S, Liu F, Nestoridi E, Hebert MJ, Ingelfinger JR (2007) Pax-2 and N-myc regulate epithelial cell proliferation and apoptosis in a positive autocrine feedback loop. Pediatr Nephrol 22:813–824PubMed Zhang SL, Chen YW, Tran S, Liu F, Nestoridi E, Hebert MJ, Ingelfinger JR (2007) Pax-2 and N-myc regulate epithelial cell proliferation and apoptosis in a positive autocrine feedback loop. Pediatr Nephrol 22:813–824PubMed
17.
Zurück zum Zitat Dressler GR, Deutsch U, Chowdhury K, Nornes HO, Gruss P (1990) Pax2, a new murine paired-box-containing gene and its expression in the developing excretory system. Development 109:787–795PubMed Dressler GR, Deutsch U, Chowdhury K, Nornes HO, Gruss P (1990) Pax2, a new murine paired-box-containing gene and its expression in the developing excretory system. Development 109:787–795PubMed
18.
Zurück zum Zitat Dressler GR, Wilkinson JE, Rothenpieler UW, Patterson LT, Williams-Simons L, Westphal H (1993) Deregulation of Pax-2 expression in transgenic mice generates severe kidney abnormalities. Nature 362:65–67PubMed Dressler GR, Wilkinson JE, Rothenpieler UW, Patterson LT, Williams-Simons L, Westphal H (1993) Deregulation of Pax-2 expression in transgenic mice generates severe kidney abnormalities. Nature 362:65–67PubMed
19.
Zurück zum Zitat Salomon R, Tellier AL, Attie-Bitach T, Amiel J, Vekemans M, Lyonnet S, Dureau P, Niaudet P, Gubler MC, Broyer M (2001) PAX2 mutations in oligomeganephronia. Kidney Int 59:457–462PubMed Salomon R, Tellier AL, Attie-Bitach T, Amiel J, Vekemans M, Lyonnet S, Dureau P, Niaudet P, Gubler MC, Broyer M (2001) PAX2 mutations in oligomeganephronia. Kidney Int 59:457–462PubMed
20.
Zurück zum Zitat Torres M, Gomez-Pardo E, Dressler GR, Gruss P (1995) Pax-2 controls multiple steps of urogenital development. Development 121:4057–4065PubMed Torres M, Gomez-Pardo E, Dressler GR, Gruss P (1995) Pax-2 controls multiple steps of urogenital development. Development 121:4057–4065PubMed
21.
Zurück zum Zitat Bates CM, Kharzai S, Erwin T, Rossant J, Parada LF (2000) Role of N-myc in the developing mouse kidney. Dev Biol 222:317–325PubMed Bates CM, Kharzai S, Erwin T, Rossant J, Parada LF (2000) Role of N-myc in the developing mouse kidney. Dev Biol 222:317–325PubMed
22.
Zurück zum Zitat Brenner BM, Garcia DL, Anderson S (1988) Glomeruli and blood pressure. Less of one, more the other? Am J Hypertens 1:335–347 Brenner BM, Garcia DL, Anderson S (1988) Glomeruli and blood pressure. Less of one, more the other? Am J Hypertens 1:335–347
23.
Zurück zum Zitat Fassi A, Sangalli F, Maffi R, Colombi F, Mohamed EI, Brenner BM, Remuzzi G, Remuzzi A (1998) Progressive glomerular injury in the MWF rat is predicted by inborn nephron deficit. J Am Soc Nephrol 9:1399–1406PubMed Fassi A, Sangalli F, Maffi R, Colombi F, Mohamed EI, Brenner BM, Remuzzi G, Remuzzi A (1998) Progressive glomerular injury in the MWF rat is predicted by inborn nephron deficit. J Am Soc Nephrol 9:1399–1406PubMed
24.
Zurück zum Zitat Menini S, Ricci C, Iacobini C, Bianchi G, Pugliese G, Pesce C (2004) Glomerular number and size in Milan hypertensive and normotensive rats: their relationship to susceptibility and resistance to hypertension and renal disease. J Hypertens 22:2185–2192PubMed Menini S, Ricci C, Iacobini C, Bianchi G, Pugliese G, Pesce C (2004) Glomerular number and size in Milan hypertensive and normotensive rats: their relationship to susceptibility and resistance to hypertension and renal disease. J Hypertens 22:2185–2192PubMed
25.
Zurück zum Zitat Suzuki H, Tokuriki T, Saito K, Hishida A, Suzuki K (2005) Glomerular hyperfiltration and hypertrophy in the rat hypoplastic kidney as a model of oligomeganephronic disease. Nephrol Dial Transplant 20:1362–1369PubMed Suzuki H, Tokuriki T, Saito K, Hishida A, Suzuki K (2005) Glomerular hyperfiltration and hypertrophy in the rat hypoplastic kidney as a model of oligomeganephronic disease. Nephrol Dial Transplant 20:1362–1369PubMed
26.
Zurück zum Zitat Hollenberg NK (2003) Nephron number in patients with primary hypertension. Curr Hypertens Rep 5:285–286PubMed Hollenberg NK (2003) Nephron number in patients with primary hypertension. Curr Hypertens Rep 5:285–286PubMed
27.
Zurück zum Zitat Keller G, Zimmer G, Mall G, Ritz E, Amann K (2003) Nephron number in patients with primary hypertension. N Engl J Med 348:101–108PubMed Keller G, Zimmer G, Mall G, Ritz E, Amann K (2003) Nephron number in patients with primary hypertension. N Engl J Med 348:101–108PubMed
28.
Zurück zum Zitat Silver LE, Decamps PJ, Korst LM, Platt LD, Castro LC (2003) Intrauterine growth restriction is accompanied by decreased renal volume in the human fetus. Am J Obstet Gynecol 188:1320–1325PubMed Silver LE, Decamps PJ, Korst LM, Platt LD, Castro LC (2003) Intrauterine growth restriction is accompanied by decreased renal volume in the human fetus. Am J Obstet Gynecol 188:1320–1325PubMed
29.
Zurück zum Zitat Weibel ER (1980) Numerical density: shape and size of particles. In: Weibel ER (ed) Sterological methods, vol 2. Theoretical foundations. Academic Press, London, pp 149–152 Weibel ER (1980) Numerical density: shape and size of particles. In: Weibel ER (ed) Sterological methods, vol 2. Theoretical foundations. Academic Press, London, pp 149–152
30.
Zurück zum Zitat Dziarmaga A, Clark P, Stayner C, Julien JP, Torban E, Goodyer P, Eccles M (2003) Ureteric bud apoptosis and renal hypoplasia in transgenic PAX2-Bax fetal mice mimics the renal-coloboma syndrome. J Am Soc Nephrol 14:2767–2774PubMed Dziarmaga A, Clark P, Stayner C, Julien JP, Torban E, Goodyer P, Eccles M (2003) Ureteric bud apoptosis and renal hypoplasia in transgenic PAX2-Bax fetal mice mimics the renal-coloboma syndrome. J Am Soc Nephrol 14:2767–2774PubMed
31.
Zurück zum Zitat Zhang SL, Chen YW, Tran S, Chenier I, Hebert MJ, Ingelfinger JR (2007) Reactive oxygen species in the presence of high glucose alter ureteric bud morphogenesis. J Am Soc Nephrol 18:2105–2115PubMed Zhang SL, Chen YW, Tran S, Chenier I, Hebert MJ, Ingelfinger JR (2007) Reactive oxygen species in the presence of high glucose alter ureteric bud morphogenesis. J Am Soc Nephrol 18:2105–2115PubMed
32.
Zurück zum Zitat Siragy HM, Inagami T, Ichiki T, Carey RM (1999) Sustained hypersensitivity to angiotensin II and its mechanism in mice lacking the subtype-2 (AT2) angiotensin receptor. Proc Natl Acad Sci USA 96:6506–6510PubMed Siragy HM, Inagami T, Ichiki T, Carey RM (1999) Sustained hypersensitivity to angiotensin II and its mechanism in mice lacking the subtype-2 (AT2) angiotensin receptor. Proc Natl Acad Sci USA 96:6506–6510PubMed
33.
Zurück zum Zitat Siragy HM, Inagami T, Carey RM (2007) NO and cGMP mediate angiotensin AT2 receptor-induced renal renin inhibition in young rats. Am J Physiol Regul Integr Comp Physiol 293:R1461–R1467PubMed Siragy HM, Inagami T, Carey RM (2007) NO and cGMP mediate angiotensin AT2 receptor-induced renal renin inhibition in young rats. Am J Physiol Regul Integr Comp Physiol 293:R1461–R1467PubMed
34.
Zurück zum Zitat Hunley TE, Tamura M, Stoneking BJ, Nishimura H, Ichiki T, Inagami T, Kon V (2000) The angiotensin type II receptor tonically inhibits angiotensin-converting enzyme in AT2 null mutant mice. Kidney Int 57:570–577PubMed Hunley TE, Tamura M, Stoneking BJ, Nishimura H, Ichiki T, Inagami T, Kon V (2000) The angiotensin type II receptor tonically inhibits angiotensin-converting enzyme in AT2 null mutant mice. Kidney Int 57:570–577PubMed
35.
Zurück zum Zitat Johren O, Dendorfer A, Dominiak P (2004) Cardiovascular and renal function of angiotensin II type-2 receptors. Cardiovasc Res 62:460–467PubMed Johren O, Dendorfer A, Dominiak P (2004) Cardiovascular and renal function of angiotensin II type-2 receptors. Cardiovasc Res 62:460–467PubMed
36.
Zurück zum Zitat Matsubara H (1998) Pathophysiological role of angiotensin II type 2 receptor in cardiovascular and renal diseases. Circ Res 83:1182–1191PubMed Matsubara H (1998) Pathophysiological role of angiotensin II type 2 receptor in cardiovascular and renal diseases. Circ Res 83:1182–1191PubMed
37.
Zurück zum Zitat Matsubara H, Inada M (1998) Molecular insights into angiotensin II type 1 and type 2 receptors: expression, signaling and physiological function and clinical application of its antagonists. Endocr J 45:137–150PubMed Matsubara H, Inada M (1998) Molecular insights into angiotensin II type 1 and type 2 receptors: expression, signaling and physiological function and clinical application of its antagonists. Endocr J 45:137–150PubMed
38.
Zurück zum Zitat Sadoshima J (2000) Cytokine actions of angiotensin II. Circ Res 86:1187–1189PubMed Sadoshima J (2000) Cytokine actions of angiotensin II. Circ Res 86:1187–1189PubMed
39.
Zurück zum Zitat Ozono R, Wang ZQ, Moore AF, Inagami T, Siragy HM, Carey RM (1997) Expression of the subtype 2 angiotensin (AT2) receptor protein in rat kidney. Hypertension 30:1238–1246PubMed Ozono R, Wang ZQ, Moore AF, Inagami T, Siragy HM, Carey RM (1997) Expression of the subtype 2 angiotensin (AT2) receptor protein in rat kidney. Hypertension 30:1238–1246PubMed
40.
Zurück zum Zitat Kakuchi J, Ichiki T, Kiyama S, Hogan BL, Fogo A, Inagami T, Ichikawa I (1995) Developmental expression of renal angiotensin II receptor genes in the mouse. Kidney Int 47:140–147PubMed Kakuchi J, Ichiki T, Kiyama S, Hogan BL, Fogo A, Inagami T, Ichikawa I (1995) Developmental expression of renal angiotensin II receptor genes in the mouse. Kidney Int 47:140–147PubMed
41.
Zurück zum Zitat Ichikawa I, Kuwayama F, Pope JC, Stephens FD, Miyazaki Y (2002) Paradigm shift from classic anatomic theories to contemporary cell biological views of CAKUT. Kidney Int 61:889–898PubMed Ichikawa I, Kuwayama F, Pope JC, Stephens FD, Miyazaki Y (2002) Paradigm shift from classic anatomic theories to contemporary cell biological views of CAKUT. Kidney Int 61:889–898PubMed
42.
Zurück zum Zitat Pope JC, Brock JW III, Adams MC, Stephens FD, Ichikawa I (1999) How they begin and how they end: classic and new theories for the development and deterioration of congenital anomalies of the kidney and urinary tract, CAKUT. J Am Soc Nephrol 10:2018–2028PubMed Pope JC, Brock JW III, Adams MC, Stephens FD, Ichikawa I (1999) How they begin and how they end: classic and new theories for the development and deterioration of congenital anomalies of the kidney and urinary tract, CAKUT. J Am Soc Nephrol 10:2018–2028PubMed
43.
Zurück zum Zitat Pope JC, Brock JW III, Adams MC, Miyazaki Y, Stephens FD, Ichikawa I (2001) Congenital anomalies of the kidney and urinary tract—role of the loss of function mutation in the pluripotent angiotensin type 2 receptor gene. J Urol 165:196–202PubMed Pope JC, Brock JW III, Adams MC, Miyazaki Y, Stephens FD, Ichikawa I (2001) Congenital anomalies of the kidney and urinary tract—role of the loss of function mutation in the pluripotent angiotensin type 2 receptor gene. J Urol 165:196–202PubMed
44.
Zurück zum Zitat Oshima K, Miyazaki Y, Brock JW III, Adams MC, Ichikawa I, Pope JC (2001) Angiotensin type II receptor expression and ureteral budding. J Urol 166:1848–1852PubMed Oshima K, Miyazaki Y, Brock JW III, Adams MC, Ichikawa I, Pope JC (2001) Angiotensin type II receptor expression and ureteral budding. J Urol 166:1848–1852PubMed
45.
Zurück zum Zitat Schedl A (2007) Renal abnormalities and their developmental origin. Nat Rev Genet 8:791–802PubMed Schedl A (2007) Renal abnormalities and their developmental origin. Nat Rev Genet 8:791–802PubMed
46.
Zurück zum Zitat Bouchard M, Souabni A, Mandler M, Neubuser A, Busslinger M (2002) Nephric lineage specification by Pax2 and Pax8. Genes Dev 16:2958–2970PubMedPubMedCentral Bouchard M, Souabni A, Mandler M, Neubuser A, Busslinger M (2002) Nephric lineage specification by Pax2 and Pax8. Genes Dev 16:2958–2970PubMedPubMedCentral
47.
Zurück zum Zitat Dziarmaga A, Quinlan J, Goodyer P (2006) Renal hypoplasia: lessons from Pax2. Pediatr Nephrol 21:26–31PubMed Dziarmaga A, Quinlan J, Goodyer P (2006) Renal hypoplasia: lessons from Pax2. Pediatr Nephrol 21:26–31PubMed
48.
Zurück zum Zitat Eccles MR (1998) The role of PAX2 in normal and abnormal development of the urinary tract. Pediatr Nephrol 12:712–720PubMed Eccles MR (1998) The role of PAX2 in normal and abnormal development of the urinary tract. Pediatr Nephrol 12:712–720PubMed
49.
Zurück zum Zitat Maeshima A, Maeshima K, Nojima Y, Kojima I (2002) Involvement of Pax-2 in the action of activin A on tubular cell regeneration. J Am Soc Nephrol 13:2850–2859PubMed Maeshima A, Maeshima K, Nojima Y, Kojima I (2002) Involvement of Pax-2 in the action of activin A on tubular cell regeneration. J Am Soc Nephrol 13:2850–2859PubMed
50.
Zurück zum Zitat Erdosova B, Wagner F, Kylarova D (2004) The detection of MYC proteins in the developing human kidney. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 148:205–207PubMed Erdosova B, Wagner F, Kylarova D (2004) The detection of MYC proteins in the developing human kidney. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 148:205–207PubMed
51.
Zurück zum Zitat Patterson LT, Dressler GR (1994) The regulation of kidney development: new insights from an old model. Curr Opin Genet Dev 4:696–702PubMed Patterson LT, Dressler GR (1994) The regulation of kidney development: new insights from an old model. Curr Opin Genet Dev 4:696–702PubMed
52.
Zurück zum Zitat Semsei I, Ma SY, Cutler RG (1989) Tissue and age specific expression of the myc proto-oncogene family throughout the life span of the C57BL/6J mouse strain. Oncogene 4:465–471PubMed Semsei I, Ma SY, Cutler RG (1989) Tissue and age specific expression of the myc proto-oncogene family throughout the life span of the C57BL/6J mouse strain. Oncogene 4:465–471PubMed
53.
Zurück zum Zitat Brezniceanu ML, Liu F, Wei CC, Chenier I, Godin N, Zhang SL, Filep JG, Ingelfinger JR, Chan JS (2008) Attenuation of interstitial fibrosis and tubular apoptosis in db/db transgenic mice overexpressing catalase in renal proximal tubular cells. Diabetes 57:451–459PubMed Brezniceanu ML, Liu F, Wei CC, Chenier I, Godin N, Zhang SL, Filep JG, Ingelfinger JR, Chan JS (2008) Attenuation of interstitial fibrosis and tubular apoptosis in db/db transgenic mice overexpressing catalase in renal proximal tubular cells. Diabetes 57:451–459PubMed
54.
Zurück zum Zitat Liu F, Brezniceanu ML, Wei CC, Chenier I, Sachetelli S, Zhang SL, Filep JG, Ingelfinger JR, Chan JS (2008) Overexpression of angiotensinogen increases tubular apoptosis in diabetes. J Am Soc Nephrol 19:269–280PubMedPubMedCentral Liu F, Brezniceanu ML, Wei CC, Chenier I, Sachetelli S, Zhang SL, Filep JG, Ingelfinger JR, Chan JS (2008) Overexpression of angiotensinogen increases tubular apoptosis in diabetes. J Am Soc Nephrol 19:269–280PubMedPubMedCentral
55.
Zurück zum Zitat Tran S, Chen YW, Chenier I, Chan JS, Quaggin S, Hebert MJ, Ingelfinger JR, Zhang SL (2008) Maternal diabetes modulates renal morphogenesis in offspring. J Am Soc Nephrol 19:943–952PubMedPubMedCentral Tran S, Chen YW, Chenier I, Chan JS, Quaggin S, Hebert MJ, Ingelfinger JR, Zhang SL (2008) Maternal diabetes modulates renal morphogenesis in offspring. J Am Soc Nephrol 19:943–952PubMedPubMedCentral
Metadaten
Titel
Deficiency of intrarenal angiotensin II type 2 receptor impairs paired homeo box-2 and N-myc expression during nephrogenesis
verfasst von
Yun-Wen Chen
Stella Tran
Isabelle Chenier
John S. D. Chan
Julie R. Ingelfinger
Tadashi Inagami
Shao-Ling Zhang
Publikationsdatum
01.10.2008
Verlag
Springer Berlin Heidelberg
Erschienen in
Pediatric Nephrology / Ausgabe 10/2008
Print ISSN: 0931-041X
Elektronische ISSN: 1432-198X
DOI
https://doi.org/10.1007/s00467-008-0854-6

Weitere Artikel der Ausgabe 10/2008

Pediatric Nephrology 10/2008 Zur Ausgabe

Klimaschutz beginnt bei der Wahl des Inhalators

14.05.2024 Klimawandel Podcast

Auch kleine Entscheidungen im Alltag einer Praxis können einen großen Beitrag zum Klimaschutz leisten. Die neue Leitlinie zur "klimabewussten Verordnung von Inhalativa" geht mit gutem Beispiel voran, denn der Wechsel vom klimaschädlichen Dosieraerosol zum Pulverinhalator spart viele Tonnen CO2. Leitlinienautor PD Dr. Guido Schmiemann erklärt, warum nicht nur die Umwelt, sondern auch Patientinnen und Patienten davon profitieren.

Zeitschrift für Allgemeinmedizin, DEGAM

Embryotransfer erhöht womöglich Leukämierisiko der Kinder

13.05.2024 Assistierte Reproduktion Nachrichten

Reproduktionsmedizinische Techniken haben theoretisch das Potenzial, den epigenetischen Code zu verändern und somit das Krebsrisiko der Kinder zu erhöhen. Zwischen Embryotransfer und Leukämie scheint sich ein solcher Zusammenhang bestätigt zu haben.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

07.05.2024 Klinik aktuell Nachrichten

Extreme Arbeitsverdichtung und kaum Supervision: Dr. Andrea Martini, Sprecherin des Bündnisses Junge Ärztinnen und Ärzte (BJÄ) über den Frust des ärztlichen Nachwuchses und die Vorteile des Rucksack-Modells.

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.